Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRR3 pseudogene 1 (PRR3P1) is a human pseudogene, meaning it is a segment of DNA resembling a protein-coding gene (in this case, likely related to PRR3/Proline Rich 3), but carries disabling mutations or structural features that prevent it from encoding a functional protein[1][4][5]. Pseudogenes were once considered genomic "junk," but many are now known to affect biological pathways by regulating their parent genes or participating as competing endogenous RNAs (ceRNAs), antisense RNAs, or sources of small interfering RNAs (siRNAs).[1] However, there is *no evidence that PRR3P1 acts as a therapeutic target, receptor, enzyme, or transporter*. Its relevance is limited to potential regulatory effects typical of pseudogenes in general, not as a functional protein or conventional molecular drug target.[1][4][5] As such, PRR3P1 is **not considered a therapeutic target** and should not be included in structured repositories of actionable drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRR3 pseudogene 1 (PRR3P1).